Topic: Illumina/Grail cases

Brazil’s competition watchdog has ordered two air mile resellers to notify their completed merger even though it falls below mandatory filing thresholds.

26 October 2023

Featured in The Guide to Life Sciences - Second Edition

The life sciences sector is a key area of concern for the European Commission. It is further tightening its grip on companies in the space, increasing its scrutiny and expanding its enforcement drive to merger review.

20 October 2023

The European Commission has confirmed how Illumina and Grail should unwind their €5.9 billion tie-up.

12 October 2023

The European Commission has issued a record gun jumping penalty against Illumina for unlawfully closing its acquisition of Grail, saying it was an “unprecedented” breach of EU merger control rules to do so before the end of its probe.

12 July 2023

Illumina and Grail have challenged the Federal Trade Commission’s constitutionality as they seek to overturn its decision ordering their merger to be unwound.

07 June 2023

The EU’s General Court has dismissed a request by the European Commission to expedite Illumina’s appeal against the authority’s decision blocking its €5.9 billion acquisition of Grail.

31 May 2023

Allegations that the Federal Trade Commission colluded with international enforcers to block Illumina’s acquisition of Grail are merely an “implausible conspiracy theory”, agency staff have said.

27 March 2023

Slaughter and May has promoted associate Lorna Nsoatabe to partner as it looks to reinforce its competition practice in London.

22 March 2023

Illumina and Grail have argued that the Federal Trade Commission’s communications with foreign competition authorities when reviewing their merger are evidence of unconstitutional influence, bias and due process violations.

08 March 2023